SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-169857
Filing Date
2022-06-08
Accepted
2022-06-08 09:08:02
Documents
12
Period of Report
2022-06-08
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d347931d8k.htm   iXBRL 8-K 24393
  Complete submission text file 0001193125-22-169857.txt   148956

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inab-20220608.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inab-20220608_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inab-20220608_pre.xml EX-101.PRE 11697
6 EXTRACTED XBRL INSTANCE DOCUMENT d347931d8k_htm.xml XML 3443
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39692 | Film No.: 221002711
SIC: 2836 Biological Products, (No Diagnostic Substances)